---
title: "Xilio Therapeutics hires Yariv Houvras as chief medical officer"
id: "stat-news-1-stat-up-and-down-the-ladder-the-latest-comings-and-goings"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-1-stat-up-and-down-the-ladder-the-latest-comings-and-goings"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "STAT News"
source_url: "https://www.statnews.com/pharmalot/2026/10/16/up-down-ladder-jobs-pharma-biotech-gilead-bausch-sanofi/?utm_campaign=rss"
published_at: "2026-10-16T14:00:13.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Xilio Therapeutics hires Yariv Houvras as chief medical officer
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-1-stat-up-and-down-the-ladder-the-latest-comings-and-goings
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/pharmalot/2026/10/16/up-down-ladder-jobs-pharma-biotech-gilead-bausch-sanofi/?utm_campaign=rss)
- **Published At:** 2026-10-16T14:00:13.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- STAT’s Pharmalot column reported that **Xilio Therapeutics** appointed **Yariv Houvras** as its new **chief medical officer**. The announcement appeared in the Oct. 16, 2026 Pharmalot roundup. - The source identified Houvras’s prior role as senior vice president of clinical and translational development at Tubulis. No additional career history or dates were provided in the story. - The column is part of a recurring Pharmalot feature that lists industry comings and goings and invites readers to submit personnel updates for publication. - The published item included a paywall element: STAT indicated that additional story content is available only to STAT+ subscribers. The public portion consisted of the hire notice and a brief invitation for submissions. - The source did not report Houvras’s start date at Xilio, specific responsibilities, reporting line, compensation, or any strategic rationale from Xilio leadership. - The article did not include comments from Xilio, Houvras, Tubulis, or independent third parties; it did not describe planned programs, therapeutic areas, or development-stage projects tied to the hire. - For organizations and individuals wanting coverage, the column reiterated its open solicitation for news about hires, promotions, and staffing changes and provided an email contact for the Pharmalot author. - Readers are left without operational or programmatic context because the source limited its disclosure; the piece functions as a personnel note rather than a detailed corporate update.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/pharmalot/2026/10/16/up-down-ladder-jobs-pharma-biotech-gilead-bausch-sanofi/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/pharmalot/2026/10/16/up-down-ladder-jobs-pharma-biotech-gilead-bausch-sanofi/?utm_campaign=rss) [STAT Summit](https://www.statnews.com/topic/stat-summit/) [Cancer](https://www.statnews.com/topic/cancer/) [Vaccines](https://www.statnews.com/topic/vaccines/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [STAT Summit](https://www.statnews.com/stat-summit-boston/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) My Account * [Settings](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing History](https://www.statnews.com/my-account/billing/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) * [Science, Shattered](https://www.statnews.com/american-science-shattered/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Wunderkinds 2026](https://www.statnews.com/wunderkinds/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) [STAT Plus](https://www.statnews.com/stat-plus/)[Pharmalot](https://www.statnews.com/category/pharma/pharmalot/) # Up and down the ladder: The latest comings and goings * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/pharmalot/2026/10/16/up-down-ladder-jobs-pharma-biotech-gilead-bausch-sanofi/?utm_campaign=rss) ![Pharmalot Coming/Going STILL](https://www.statnews.com/wp-content/uploads/2021/03/Pharmalot_ComingGoing_STILL-645x645.jpg) Alex Hogan/STAT ![](https://www.statnews.com/wp-content/uploads/2021/02/ed-s-avatar-small4-80x80.png) By [Ed Silverman](https://www.statnews.com/staff/ed-silverman/) Oct. 16, 2026 Pharmalot Columnist, Senior Writer ![](https://www.statnews.com/wp-content/uploads/2021/02/ed-s-avatar-small4-80x80.png) [Ed Silverman](https://www.statnews.com/staff/ed-silverman/) 1. [](https://www.linkedin.com/in/edsilverman/ "Linkedin") 2. [](https://x.com/Pharmalot "X") ed.silverman@statnews.com Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning [Pharmalittle newsletter](https://www.statnews.com/signup/pharmalittle/) and the afternoon [Pharmalot newsletter](https://www.statnews.com/signup/pharmalot/). Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. **That’s right. Send us your changes, and we’ll find a home for them**. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week. This time around, we note that **Xilio Therapeutics** hired Yariv Houvras as chief medical officer. Previously, he was senior vice president of clinical and translational development at Tubulis. Advertisement **But all work and no play can make for a dull chief medical officer.** [![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo.svg)](https://www.statnews.com/stat-plus/) To read the rest of this story subscribe to STAT+. [Subscribe](https://www.statnews.com/stat-plus/) [Log In](https://www.statnews.com/login/) [biotechnology](https://www.statnews.com/topic/biotechnology/), [jobs](https://www.statnews.com/topic/jobs/), [Pharmaceuticals](https://www.statnews.com/topic/pharmaceuticals/), [STAT+](https://www.statnews.com/topic/stat-plus/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. ![](https://www.statnews.com/wp-content/uploads/2021/02/ed-s-avatar-small4-80x80.png) [Ed Silverman](https://www.statnews.com/staff/ed-silverman/) 1. [](https://x.com/Pharmalot "X") 2. 3. [](https://www.linkedin.com/in/edsilverman/ "Linkedin") Pharmalot Columnist, Senior Writer 1. [](https://x.com/Pharmalot "X") 2. 3. [](https://www.linkedin.com/in/edsilverman/ "Linkedin") Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning [Pharmalittle newsletter](https://www.statnews.com/signup/pharmalittle/) and the afternoon [Pharmalot newsletter](https://www.statnews.com/signup/pharmalot/). ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/Pharmalot-Logo-Black-640x111.png) ### Newsletter From the lab to the medicine chest, these are the must-read drug industry updates of the day Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2025/07/GettyImages-2208174977-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [In DOGE’s aftermath, federal health workers bristle at new performance reviews](https://www.statnews.com/2026/10/16/federal-performance-reviews-health-agency-employees-wary-after-doge/) 2. ![](https://www.statnews.com/wp-content/uploads/2023/01/Holmes-flight-risk-80x80.jpg) [What to read before you go see that new documentary on Elizabeth Holmes](https://www.statnews.com/2026/10/16/health-news-what-to-read-before-elizabeth-holmes-you-can-see-everything/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/10/STATday2269-80x80.jpg) [Merck and Moderna have ‘lot of exploring to do’ after initial cancer vaccine success](https://www.statnews.com/2026/10/15/moderna-merck-keytruda-mrna-cancer-vaccine-strategy/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/10/unnamed-1-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [On Wall Street, there’s trouble stirring for biotech](https://www.statnews.com/2026/10/15/wall-street-biotech-trouble-stirring/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/08/AP26215050550263-80x80.jpg) [Trump administration advances plan for peptide drugs favored by RFK Jr.](https://www.statnews.com/2026/10/15/trump-administration-advances-plan-peptides-rfk-jr/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2026/08/2026_CancerReport_ReportCover-328x424.jpg) Explore Cancer’s transformational moments: KRAS, CAR-T, immunotherapy, and more ](https://reports.statnews.com/products/cancer-transformational-moments-advances-in-kras-car-t-immunotherapy) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/01/Flagship2026_Wordpress_CalendarImageRegGoLive-1-80x80.jpg) 2026 STAT Summit Boston, MA Oct 14 ](https://www.statnews.com/event/2026-stat-summit/) [ ![](https://www.statnews.com/wp-content/uploads/2026/09/TevaPF_Wordpress_CalendarImage-80x80.jpg) The Next Era of Biosimilars: Rewriting the Playbook Virtual Oct 19 ](https://www.statnews.com/event/next-era-of-biosimilars-rewriting-the-playbook/) [ ![](https://www.statnews.com/wp-content/uploads/2026/09/ESMORecap_Wordpress_CalendarImage-80x80.jpg) ESMO 2026: The STAT Recap Virtual Oct 29 ](https://www.statnews.com/event/esmo-2026-the-stat-recap/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Pharmalot Pharmalot October 16, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Pharmalittle: We’re reading about an HHS peptide push, Trump’s pharma stock holdings, and more ](https://www.statnews.com/pharmalot/2026/10/16/hhs-peptide-push-trump-pharma-stock-holdings/) By [Ed Silverman](https://www.statnews.com/staff/ed-silverman/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Pharmalot Pharmalot October 15, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Pharmalittle: We’re reading about former FDA head calling DOGE a ‘disaster,’ an AstraZeneca AI deal, and more ](https://www.statnews.com/pharmalot/2026/10/15/former-fda-commissioner-califf-criticized-doge-astrazeneca-ai-deal/) By [Ed Silverman](https://www.statnews.com/staff/ed-silverman/) Advertisement ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Pharmalot Pharmalot October 14, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Trump administration delays new rule that could restrict imported medicines from Canada and overseas ](https://www.statnews.com/pharmalot/2026/10/14/trump-administration-delays-new-rule-that-could-restrict-imported-meds-from-canad-and-overseas/) By [Ed Silverman](https://www.statnews.com/staff/ed-silverman/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Pharmalot Pharmalot October 14, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Pharmalittle: We’re reading about Sanofi settling an EU antitrust probe, ‘pharma bro’ Shkreli, and more ](https://www.statnews.com/pharmalot/2026/10/14/sanofi-settling-european-antitrust-probe-pharma-bro-shkreli/) By [Ed Silverman](https://www.statnews.com/staff/ed-silverman/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Pharmalot Pharmalot October 14, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Sanofi avoids fine as EU accepts offer to end antitrust probe over disparaging rival vaccine ](https://www.statnews.com/pharmalot/2026/10/14/sanofi-avoids-fine-as-eu-accepts-offer-ends-antitrust-probe-over-disparaging-rival-vaccine/) By [Ed Silverman](https://www.statnews.com/staff/ed-silverman/) #### Subscriber Picks 1. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Concerns grow on safety issues tied to Neurocrine Biosciences rare disease drug ](https://www.statnews.com/2026/10/13/neurocrine-biosciences-prader-willi-vykat-xr/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 2. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Lobbyists and trade groups fight to shape how states regulate medical AI ](https://www.statnews.com/2026/10/14/lobbyists-trade-groups-ama-push-autonomous-clinical-ai-regulations/) By [Mario Aguilar](https://www.statnews.com/staff/mario-aguilar/) 3. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Why this startup is taking its AI to predict breast cancer risk directly to patients ](https://www.statnews.com/2026/10/08/why-clairity-took-breast-cancer-risk-prediction-ai-directly-to-patients/) By [Katie Palmer](https://www.statnews.com/staff/katie-palmer/) 4. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: On Wall Street, there's trouble stirring for biotech ](https://www.statnews.com/2026/10/15/wall-street-biotech-trouble-stirring/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 5. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: The epidemic of learned helplessness in physicians ](https://www.statnews.com/2026/10/13/doctors-learned-helplessness-chief-complaint-frances-mei-hardin/) By Frances Mei Hardin Share options * [ X ](https://twitter.com/intent/tweet?url=https://www.statnews.com/pharmalot/2026/10/16/up-down-ladder-jobs-pharma-biotech-gilead-bausch-sanofi/&via=statnews&text=Up%20and%20down%20the%20ladder%3A%20The%20latest%20comings%20and%20goings "Share on X") * [ Bluesky ](https://bsky.app/intent/compose?text=Up%20and%20down%20the%20ladder%3A%20The%20latest%20comings%20and%20goings%20https://www.statnews.com/pharmalot/2026/10/16/up-down-ladder-jobs-pharma-biotech-gilead-bausch-sanofi/%20via%20@statnews.com "Share on Bluesky") * [ LinkedIn ](https://www.linkedin.com/shareArticle?url=https://www.statnews.com/pharmalot/2026/10/16/up-down-ladder-jobs-pharma-biotech-gilead-bausch-sanofi/&mini=true&source=STAT "Linkedin") * [ Facebook ](https://www.facebook.com/sharer/sharer.php?u=https://www.statnews.com/pharmalot/2026/10/16/up-down-ladder-jobs-pharma-biotech-gilead-bausch-sanofi/ "Facebook") * Email * [ Doximity ](https://www.doximity.com/inbox/conversations/new_message?url=https%3A%2F%2Fwww.statnews.com%2Fpharmalot%2F2026%2F10%2F16%2Fup-down-ladder-jobs-pharma-biotech-gilead-bausch-sanofi%2F&subject=Up%20and%20down%20the%20ladder%3A%20The%20latest%20comings%20and%20goings "Doximity") * Copy link * [ Reprints ](https://www.parsintl.com/publications/stat/ "Reprints") [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Reporting from the frontiers of health and medicine * [](https://flipboard.com/@STATnews "Flipboard") * [](https://x.com/statnews/ "X") * [](https://www.linkedin.com/company/stat-news/ "LinkedIn") * [](https://www.facebook.com/statnews/ "Facebook") * [](https://www.youtube.com/channel/UC89FjSf9AT1O2qw6vxrrxDQ "Youtube") * [](https://www.instagram.com/statnews/ "Instagram") * [](https://www.threads.com/@statnews/ "Threads") [Back to top](https://www.statnews.com/pharmalot/2026/10/16/up-down-ladder-jobs-pharma-biotech-gilead-bausch-sanofi/?utm_campaign=rss) Company * [About](https://www.statnews.com/about/) * [Our Team](https://www.statnews.com/staff) * [Contact Us](https://www.statnews.com/contact/) * [Careers](https://www.statnews.com/careers/) * [Diversity & Inclusion](https://www.statnews.com/about/diversity-and-inclusion/) * [Awards](https://www.statnews.com/stat-awards/) * [Advertise With Us](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com) * [Licensing Stories](https://www.parsintl.com/publications/stat/) Account * [STAT+](https://www.statnews.com/stat-plus/) * [STAT+ Discounts](https://www.statnews.com/stat-subscription-discounts-students-educators-healthcare-workers/) * [Group Subscriptions](https://www.statnews.com/stat-plus/group-subscriptions/?stat_plus_group_source=sitefooter) * [FAQ](h
## Related Clinical Research

- [Understanding Patient Nonadherence: The Complex Reality Behind Stopping Medications](https://medichelpline.com/clinical-feed/stat-news-3-opinion-i-thought-i-knew-why-patients-stopped-taking-their-medicine-i-was-wrong.md)
- [FDA to Continue Safety Review of Mifepristone Into 2027, Report Expected by March](https://medichelpline.com/clinical-feed/stat-news-0-fda-says-its-safety-review-of-abortion-pill-will-continue-into-next-year.md)
- [Semaglutide plus menopause hormone therapy linked to greater weight loss in midlife women](https://medichelpline.com/clinical-feed/medical-news-today-0-ozempic-plus-hormone-therapy-may-help-boost-weight-loss-at-menopause.md)
- [High-Fiber Diet Outperforms Metformin in Blood Sugar Control and Weight Loss](https://medichelpline.com/clinical-feed/medical-news-today-0-high-fiber-diet-vs-metformin-which-is-better-for-blood-sugar-control-weight-loss.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.